Abstract
Interferons (IFNs) and retinoids are potent tumor growth suppressors. We have shown earlier that the IFN-β and all-trans retinoic acid combination, but not the single agents, induces death in several tumor cell lines. Employing a genetic approach we have recently identified several Genes associated with Retinoid-IFN induced Mortality (GRIM) that mediate the cell death effect of IFN/RA combination. One of the GRIMs, GRIM-12, was identical to human thioredoxin reductase (TR), an enzyme that controls intracellular redox state. To define the participants of TR mediated death pathway we have examined the role of thioredoxin (Trx), its downstream substrate, and its influence on IFN/RA-induced death regulation. Inhibition of the thioredoxin expression by antisense RNA suppressed cell death. Similarly, a mutant Trx1 lacking the critical cysteine residues blocked cell death. In contrast, overexpression of wildtype thioredoxin augmented cell death. This effect of Trx1 was in part due to its ability to augment cell death via caspase-8. The redox inactive Trx1 mutant inhibits the cell death induced by caspase-8 but not caspase-3. These studies identify a novel mechanism of cell death regulation by IFN/RA combination involving redox enzymes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- FLIP:
-
FLICE-inhibitory protein
- GRIM:
-
Genes associated with Retinoid-IFN induced mortality
- IFN:
-
Interferon
- JAK:
-
Janus tyrosine kinase
- RA:
-
all trans retinoic acid
- SRB:
-
Sulforhodamine B
- STAT:
-
Signal transducing activator of transcription
- TR:
-
thioredoxin reductase
- Trx:
-
thioredoxin
References
Alnemri ES, Fernandes-Alnemri T, Litwack G . 1995 J. Biol. Chem. 270: 4312–4317
Arner ES, Holmgren A . 2000 Eur. J. Biochem. 267: 6102–6109
Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN . 1998 EMBO J. 17: 6888–6902
Berlett BS, Stadtman ER . 1997 J. Biol. Chem. 272: 20313–20316
Cao L, Yao Y, Lee V, Kiani C, Spaner D, Lin Z, Zhang Y, Adams ME, Yang BB . 2000 J. Cell. Biochem. 77: 569–583
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC . 1998 Science 282: 1318–1321
Casso D, Beach D . 1996 Mol. Gen. Genet. 252: 518–529
Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de The H . 1998 J. Virol. 72: 1043–1051
Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY . 1997 Mol. Cell. Biol. 17: 5328–5337
Choubey D, Li SJ, Datta B, Gutterman JU, Lengyel P . 1996 EMBO J. 15: 5668–5678
Darnell Jr JE, Kerr IM, Stark GR . 1994 Science 264: 1415–1421
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME . 1997 Cell 91: 231–241
Deiss LP, Kimchi A . 1991 Science 252: 117–120
Der SD, Yang YL, Weissmann C, Williams BR . 1997 Proc. Natl. Acad. Sci. USA 94: 3279–3283
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC . 1992 Cell 69: 119–128
Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM, Orkin SH, Greenberg ME . 1996 Cell 85: 549–561
Gaboli M, Gandini D, Delva L, Wang ZG, Pandolfi PP . 1998 Leuk. Lymphoma 30: 11–22
Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, Powis G . 1996 Cancer Res. 56: 5765–5770
Gianni M, Terao M, Fortino I, LiCalzi M, Viggiano V, Barbui T, Rambaldi A, Garattini E . 1997 Blood 89: 1001–1012
Glass CK, Rose DW, Rosenfeld MG . 1997 Curr. Opin. Cell. Biol. 9: 222–232
Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, Mechti N . 1997 J. Biol. Chem. 272: 19457–19463
Green DR, Reed JC . 1998 Science 281: 1309–1311
Gross A, McDonnell JM, Korsmeyer SJ . 1999 Genes. Dev. 13: 1899–1911
Gutterman JU . 1994 Proc. Natl. Acad. Sci. USA 91: 1198–1205
Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, Scott JD, Korsmeyer SJ . 1999 Mol. Cell. 3: 413–422
Hartman H, Wu M, Buchanan BB, Gerhart JC . 1993 Proc. Natl. Acad. Sci. USA 90: 2271–2275
Hermeking H, Eick D . 1994 Science 265: 2091–2093
Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J . 1997 Proc. Natl. Acad. Sci. USA 94: 3633–3638
Hofmann ER, Boyanapalli M, Lindner DJ, Weihua X, Hassel BA, Jagus R, Gutierrez PL, Kalvakolanu DV . 1998 Mol. Cell. Biol. 18: 6493–6504
Holmgren A, Bjornstedt M . 1995 Methods Enzymol. 252: 199–208
Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch KP, Gabriele L, Waring J, Bachmann MF, Zinkernagel RM, Morse HC, Ozato K, Horak I . 1996 Cell 87: 307–317
Janicke RU, Sprengart ML, Wati MR, Porter AG . 1998 J. Biol. Chem. 273: 9357–9360
Kalvakolanu DV . 2000 Histol. Histopathol. 15: 523–537
Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD . 1998 Proc. Natl. Acad. Sci. USA 95: 7556–7561
Kennedy SG, Kandel ES, Cross TK, Hay N . 1999 Mol. Cell. Biol. 19: 5800–5810
Kolla V, Weihua X, Kalvakolanu DV . 1997 J. Biol. Chem. 272: 9742–9748
Kurooka H, Kato K, Minoguchi S, Takahashi Y, Ikeda J, Habu S, Osawa N, Buchberg AM, Moriwaki K, Shisa H, Honjo T . 1997 Genomics 39: 331–339
Kuwata T, Wang IM, Tamura T, Ponnamperuma RM, Levine R, Holmes KL, Morse HC, De Luca LM, Ozato K . 2000 Blood 95: 3349–3356
Lee HY, Dohi DF, Kim YH, Walsh GL, Consoli U, Andreeff M, Dawson MI, Hong WK, Kurie JM . 1998a J. Clin. Invest. 101: 1012–1019
Lee KK, Murakawa M, Takahashi S, Tsubuki S, Kawashima S, Sakamaki K, Yonehara S . 1998b J. Biol. Chem. 273: 19160–19166
Lee SR, Kim JR, Kwon KS, Yoon HW, Levine RL, Ginsburg A, Rhee SG . 1999 J. Biol. Chem. 274: 4722–4734
Levy-Strumpf N, Kimchi A . 1998 Oncogene 17: 3331–3340
Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin B, Chen G, Lu J, Lin F, Xie Z, Fontana JA, Reed JC, Zhang X . 2000 Science 289: 1159–1164
Lindner DJ, Borden EC, Kalvakolanu DV . 1997 Clin. Cancer Res. 3: 931–937
Lindner DJ, Hofmann ER, Karra S, Kalvakolanu DV . 2000 Biochim. Biophys. Acta. 1496: 196–206
Lipton SA . 1999 Cell. Death. Differ. 6: 943–951
Liu H, Nishitoh H, Ichijo H, Kyriakis JM . 2000 Mol. Cell. Biol. 20: 2198–2208
Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X . 1996 Mol. Cell. Biol. 16: 1138–1149
Lotan R . 1996 FASEB J. 10: 1031–1039
Love JM, Gudas LJ . 1994 Curr. Opin. Cell. Biol. 6: 825–831
Mangelsdorf DJ, Evans RM . 1995 Cell 83: 841–850
Matikainen S, Ronni T, Lehtonen A, Sareneva T, Melen K, Nordling S, Levy DE, Julkunen I . 1997 Cell. Growth. Differ. 8: 687–698
Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, Taketo MM . 1996 Dev. Biol. 178: 179–185
Mohr S, Zech B, Lapetina EG, Brune B . 1997 Biochem. Biophys. Res. Commun. 238: 387–391
Moore DM, Kalvakolanu DV, Lippman SM, Kavanagh JJ, Hong WK, Borden EC, Paredes-Espinoza M, Krakoff IH . 1994 Semin. Hematol. 31: 31–37
Muller EG . 1991 J. Biol. Chem. 266: 9194–9202
Nakamura H, Nakamura K, Yodoi J . 1997 Annu. Rev. Immunol. 15: 351–369
Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Seale JR, Cross NC, Goldman JM, Dmitrovsky E, Pandolfi PP . 1996 Blood 88: 3926–3936
Pearson GD, Merrill GF . 1998 J. Biol. Chem. 273: 5431–5434
Pelicano L, Li F, Schindler C, Chelbi-Alix MK . 1997 Oncogene 15: 2349–2359
Pellicena-Palle A, Stitzinger SM, Salz HK . 1997 Mech. Dev. 62: 61–65
Piedrafita FJ, Pfahl M . 1997 Mol. Cell. Biol. 17: 6348–6358
Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ, Johnson DG . 1999 Mol. Cell. Biol. 19: 6408–6414
Pierce RH, Campbell JS, Stephenson AB, Franklin CC, Chaisson M, Poot M, Kavanagh TJ, Rabinovitch PS, Fausto N . 2000 Am. J. Pathol. 157: 221–236
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . 1997 Nature 389: 300–305
Raveh T, Hovanessian AG, Meurs EF, Sonenberg N, Kimchi A . 1996 J. Biol. Chem. 271: 25479–25484
Resnitzky D, Tiefenbrun N, Berissi H, Kimchi A . 1992 Proc. Natl. Acad. Sci. USA 89: 402–406
Rubartelli A, Bonifaci N, Sitia R . 1995 Cancer Res. 55: 675–680
Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H . 1998 EMBO J. 17: 2596–2606
Salz HK, Flickinger TW, Mittendorf E, Pellicena-Palle A, Petschek JP, Albrecht EB . 1994 Genetics 136: 1075–1086
Sen CK, Sashwati R, Packer L . 1999 Cell. Death. Differ. 6: 481–491
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR . 1990 J. Natl. Cancer Inst. 82: 1107–1112
Spyrou G, Enmark E, Miranda-Vizuete A, Gustafsson J . 1997 J. Biol. Chem. 272: 2936–2941
Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, Gladyshev VN . 1999 J. Biol. Chem. 274: 24522–24530
Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R . 2000 Clin. Cancer Res. 6: 1563–1573
Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, Yodoi J . 1989 EMBO J. 8: 757–764
Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J . 1997 Nature 386: 517–521
Tiefenbrun N, Melamed D, Levy N, Resnitzky D, Hoffman I, Reed SI, Kimchi A . 1996 Mol. Cell. Biol. 16: 3934–3944
Ueda S, Nakamura H, Masutani H, Sasada T, Yonehara S, Takabayashi A, Yamaoka Y, Yodoi J . 1998 J. Immunol. 161: 6689–6695
Wagner AJ, Kokontis JM, Hay N . 1994 Genes. Dev. 8: 2817–2830
Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP . 1998 Science 279: 1547–1551
Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T . 1993 Science 259: 968–971
Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ . 2000 Science 290: 1761–1765
Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH . 1997 EMBO J. 16: 6355–6363
Acknowledgements
These studies are supported by the National Cancer Institute grants CA 78282 and CA 71401 to DV Kalvakolanu and National Institutes of Health grant HL-58122 to SPM Reddy. We thank E Alnemri, and J Tschopp, for providing plasmids used in this study.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ma, X., Karra, S., Lindner, D. et al. Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination. Oncogene 20, 3703–3715 (2001). https://doi.org/10.1038/sj.onc.1204477
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204477
Keywords
This article is cited by
-
Thioredoxin Decreases Anthracycline Cardiotoxicity, But Sensitizes Cancer Cell Apoptosis
Cardiovascular Toxicology (2021)
-
Role of manganese superoxide dismutase in cancer
Nature Medicine (2003)
-
Reply to “Role of manganese superoxide dismutase in cancer”
Nature Medicine (2003)
-
Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation
Oncogene (2002)